TITAN PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Titan Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2012 to Q2 2024.
  • Titan Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 914K shares, a 21.7% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 752K shares, a 11.9% increase from 2022.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 672K shares, a 93.1% decline from 2021.
  • Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 9.73M shares, a 158% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 914K +163K +21.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 853K +102K +13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 752K +80K +11.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 15M +387K +2.65% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 751K -12.9M -94.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 751K -9.98M -93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 672K -9.06M -93.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 14.6M +4.77M +48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 13.7M +3.83M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 10.7M +1.44M +15.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 9.73M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-25
Q3 2021 9.86M +6.6M +202% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 9.86M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 9.29M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 3.26M -12.3M -79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 15.5M +15.5M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q4 2018 5.69M +2.15M +60.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 3.65K* -21.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 21.2M 0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 21.2M -172K -0.81% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q4 2017 3.54M -39K -1.09% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 21.2M +5K +0.02% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 21.2M -674K -3.08% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 21.4M +976K +4.78% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 3.58M -16.5M -82.2% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 21.2M +1.14M +5.68% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 21.9M +1.81M +8.99% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 20.4M +344K +1.72% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 20.1M +2.99M +17.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 20.1M +3.81M +23.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 20.1M -68.9M -77.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 20.1M -68.9M -77.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 17.1M +2.03M +13.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 16.2M -66.3M -80.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 89M +6.44M +7.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 88.9M +2.17M +2.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 15M -51.5M -77.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 82.5M +15.7M +23.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 82.6M +17.6M +27% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 86.8M +27.4M +46.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 66.5M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 66.8M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 65M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 59.4M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.